Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma

Published:2014-01-15 Issue:6 Volume:16 Page:880-888
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro-Oncology

Author:

Schmainda K. M.,Prah M.,Connelly J.,Rand S. D.,Hoffman R. G.,Mueller W.,Malkin M. G.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/16/6/880/6907014/not216.pdf

Reference34 articles.

1. Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

3. Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

4. Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

5. Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a Single-Dose, Low-Flip-Angle–Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma;American Journal of Neuroradiology;2024-05-23

2. Practical guidance to identify and troubleshoot suboptimal DSC-MRI results;Frontiers in Radiology;2024-02-20

3. Contrast‐free dynamic susceptibility contrast using sinusoidal and bolus oxygenation challenges;NMR in Biomedicine;2024-01-31

4. Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors;Cancers;2024-01-30

5. Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma;Frontiers in Oncology;2024-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3